These findings were consistent with the results of Ma et al.; in their study, a selective inhibition of SIRT1 and SIRT2 impaired the survival of pediatric rhabdomyosarcoma and synovial sarcoma cell lines [28]. Here, SIRT2 is linked to rhabdomyosarcoma.